I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
PARP inhibition is a modulator of anti-tumor immune respons..:
Anna D. Staniszewska
;
Joshua Armenia
;
Matthew King
...
https://www.tandfonline.com/doi/10.1080/2162402X.2022.2083755. , 2022
Link:
https://doi.org/10.1080/2162402X.2022.2083755
RT Journal T1
PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:42e14e70567c4dc0ac16e7566635a844&Exemplar=1&LAN=DE A1 Anna D. Staniszewska A1 Joshua Armenia A1 Matthew King A1 Chrysiis Michaloglou A1 Avinash Reddy A1 Maneesh Singh A1 Maryann San Martin A1 Laura Prickett A1 Zena Wilson A1 Theresa Proia A1 Deanna Russell A1 Morgan Thomas A1 Oona Delpuech A1 Mark J. O'Connor A1 Elisabetta Leo A1 Helen Angell A1 Viia Valge-Archer PB Taylor & Francis Group YR 2022 K1 PARP inhibitor K1 olaparib K1 cGAS-STING K1 immune checkpoint blockade K1 BRCA K1 Immunologic diseases. Allergy K1 RC581-607 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.tandfonline.com/doi/10.1080/2162402X.2022.2083755 LK http://dx.doi.org/https://doi.org/10.1080/2162402X.2022.2083755 DO https://doi.org/10.1080/2162402X.2022.2083755 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)